Summary: Donation of CCP, Blood Components and HCT/Ps, Including Information on COVID-19 Vaccines or Treatment with CCP or Monoclonals (updated 04/14/21)
This section contains information on questionnaires used to screen prospective donors and help ensure the safety of the donation process as well as the product being donated. AABB has played a leadership role in the development of model questionnaires for blood collection facilities as well as for facilities involved in the collection of hematopoietic progenitor cells (HPCs).
FDA Issues Important Information Regarding Oropouche Virus and Blood Donation
September 16, 2024
AABB Issues Emergent Standards to 34th Edition of BB/TS Standards and 11th Edition of CT Standards
August 02, 2024
July 19, 2024
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
